Research
The Science
Every compound in Lumivux is here for a reason — and delivered via nasal mucosa for a reason. Here's the research.
How We Formulate
Before any bottle ships.
Active Compound
One compound.
Everything it does.
† These statements have not been evaluated by the FDA.
GHK-Cu Tripeptide Complex
GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring tripeptide found in human blood plasma. It was first identified in 1973 and has since been studied extensively for its role in cellular repair, collagen synthesis, antioxidant defense, and gene expression regulation — activating over 4,000 human genes by some estimates.
Why nasal delivery
Plasma GHK-Cu levels decline sharply with age — from approximately 200 ng/mL at age 20 to under 80 ng/mL by age 60. Oral delivery is subject to first-pass hepatic metabolism, which degrades the tripeptide before it reaches systemic circulation. Nasal transmucosal delivery bypasses this pathway entirely, allowing GHK-Cu to enter the bloodstream directly through the nasal mucosa.
Pickart L (2008), Wound Repair Regen. Mulder GD (2015), Adv Wound Care. Pickart L, Vasquez-Soltero JM (2016), Biomolecules.
Certificate of Analysis
Every batch has a COA from an independent accredited lab. To request the COA for your specific lot number, email [email protected] with your order number.
† These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.